EPISODE · Oct 8, 2012 · 8 MIN
Outcome in Systemic Anaplastic Large Cell Lymphoma: Beyond ALK
from Journal of Clinical Oncology (JCO) Podcast
The prognostic importance of ALK-protein expression was established over a decade ago. More recent studies emphasize that age is also an important driving force and in patients <40 years, the distinction between ALK-positive and ALK-negative ALCL is less clear.
Embed this episode
NOW PLAYING
Outcome in Systemic Anaplastic Large Cell Lymphoma: Beyond ALK
0:00
8:57
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 8 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on October 8, 2012.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!